These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17027704)

  • 1. Institute of Medicine urges reforms at FDA.
    Lancet; 2006 Oct; 368(9543):1211. PubMed ID: 17027704
    [No Abstract]   [Full Text] [Related]  

  • 2. Protecting the health of the public--Institute of Medicine recommendations on drug safety.
    Psaty BM; Burke SP
    N Engl J Med; 2006 Oct; 355(17):1753-5. PubMed ID: 17030843
    [No Abstract]   [Full Text] [Related]  

  • 3. Institute of Medicine urges colleges to improve research integrity.
    J Investig Med; 2002 Nov; 50(6):390. PubMed ID: 12425414
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA responds to institute of medicine drug safety recommendations--in part.
    Psaty BM; Charo RA
    JAMA; 2007 May; 297(17):1917-20. PubMed ID: 17473302
    [No Abstract]   [Full Text] [Related]  

  • 5. The Institute of Medicine report on the FDA: where is the science?
    Philipson T; Jena AB; Sun E
    Health Econ; 2007 Mar; 16(3):219-21. PubMed ID: 17315264
    [No Abstract]   [Full Text] [Related]  

  • 6. Can the Institute of Medicine review the FDA?
    Carroll BJ
    Nat Med; 2005 Apr; 11(4):369. PubMed ID: 15812509
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to the Institute of Medicine's recommendation that cost determine insurance policies' "essential benefits".
    Himmelstein D
    Int J Health Serv; 2012; 42(3):571-3. PubMed ID: 22993971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply to "Can the Institute of Medicine review the FDA?".
    Fineberg HV
    Nat Med; 2005 Jun; 11(6):589. PubMed ID: 15937463
    [No Abstract]   [Full Text] [Related]  

  • 9. IOM urges FDA to be more aggressive in monitoring safety of approved drugs.
    Kuehn BM
    JAMA; 2012 Jun; 307(23):2475-6. PubMed ID: 22797430
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA unveils 25 initial 510(k) changes, refers controversial recommendations to the Institute of Medicine (IOM).
    Gilmore M; Hylak-Reinholtz JJ
    Health Care Law Mon; 2011 Jun; 2011(6):2-7. PubMed ID: 21748924
    [No Abstract]   [Full Text] [Related]  

  • 11. Remarks of the Acting FDA Commissioner: FDLI's 48th annual conference.
    Crawford LM
    Food Drug Law J; 2005; 60(2):99-102. PubMed ID: 16097087
    [No Abstract]   [Full Text] [Related]  

  • 12. The USA's healthcare debacle: the role of the US FDA.
    Grillo-López AJ
    Expert Rev Anticancer Ther; 2010 May; 10(5):607-8. PubMed ID: 20469989
    [No Abstract]   [Full Text] [Related]  

  • 13. Institute of Medicine, Congress seek solutions to FDA's safety woes through reform, funding.
    Finkelstein JB
    J Natl Cancer Inst; 2007 Jan; 99(2):104-7. PubMed ID: 17227990
    [No Abstract]   [Full Text] [Related]  

  • 14. IOM: congress must reform FDA to improve drug safety.
    Young D
    Am J Health Syst Pharm; 2006 Nov; 63(21):2032, 2034. PubMed ID: 17057032
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA Commissioner, Deputy receive IOM appointments.
    FDA Consum; 2004; 38(1):2. PubMed ID: 15032180
    [No Abstract]   [Full Text] [Related]  

  • 16. The future of drug safety: what the IOM report may mean to the emergency department.
    Berger E
    Ann Emerg Med; 2007 Feb; 49(2):193-5. PubMed ID: 17245837
    [No Abstract]   [Full Text] [Related]  

  • 17. The FDA and the IOM report.
    Galson SK
    N Engl J Med; 2007 Dec; 357(24):2520-1; author reply 2521-2. PubMed ID: 18077820
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA should tighten post-marketing surveillance of prescription drugs, says Institute of Medicine.
    Roehr B
    BMJ; 2012 May; 344():e3104. PubMed ID: 22549070
    [No Abstract]   [Full Text] [Related]  

  • 19. Nutrition labeling: issues and directions for the 1990s.
    Earl R; Porter DV; Wellman NS
    J Am Diet Assoc; 1990 Nov; 90(11):1599-601. PubMed ID: 2229858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the Institute of Medicine.
    Lohr KN; Grossman JH; Cassel CK
    JAMA; 1993 Oct; 270(16):1911. PubMed ID: 8411537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.